For their study, investigators led by Bohdan Pomahac, MD, of Brigham and Women’s Hospital and Harvard Medical School, followed three full-face transplant recipients over 36 months. Dr. Pomahac led the team that performed the first full-face transplant in United States and the third overall in the world.
The group noted a significant decrease in facial volume in patients that resembled premature aging but was driven by a reduction in volume of bone and muscle, not facial fat or skin thickness as is seen with normal facial aging. The findings suggest the need for effective countermeasures to reverse, delay, or even prevent muscle and bone atrophy in order to sustain the aesthetic outcomes of face transplants.
“The field of face transplantation is young, and we are all learning about our interventions and their outcomes. We studied why transplanted faces seem to age fast as well as we could, but we don’t really know many other things: When does this process end? Is it possibly a sign of inadequate blood supply or ongoing rejection?” noted Dr. Pomahac. “As often occurs in science, our study raises more questions than it answered.” He added that the findings have implications for patients and their expectations, and they may impact the way surgeons plan face transplant operations. “But first we have to understand what’s exactly going on, and we are not there yet.”
The National Organ Transplant Act was revised just last year to expand the definition of organs to include vascularized composite allografts, which includes faces. Because face transplantation is a non-life-saving procedure with potential life-threatening side effects, it presents unique ethical challenges that require long-term studies to better understand its risks and benefits.
Media wishing to receive a PDF of this article may contact email@example.com. (Would you prefer to access this paper instantly? You can register for a login to our Press Room here.)
Full citation: ““Transformation of Face Transplants: Volumetric and Morphologic Graft Changes Resemble Aging after Facial Allotransplantation.” Maximilian Kueckelhaus, Marvee Turk, Kanako Kumamaru, Luccie Wo, Ericka M. Bueno, Christine G. Lian, Muayyad Alhefzi, Mario A. Aycart, Sebastian Fischer, Umberto De Girolami, George F. Murphy, Frank J. Rybicki, and Bohdan Pomahac. American Journal of Transplantation; Published Online: December 3, 2015 (DOI: 10.1111/ajt.13544).
URL Upon Publication: http://doi.wiley.com/10.1111/ajt.13544
About the Author:
To arrange an interview with the author, please contact Lori J. Schroth from Brigham & Women’s Hospital LSCHROTH@BWH.HARVARD.EDU.
About the Journal:
American Journal of Transplantation (AJT) is the official journal of the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS). This #1 ranked transplantation journal serves as a forum for debate and re-assessment and is a major platform for promoting understanding, improving results and advancing science in this dynamic field. Published monthly, AJT provides an essential resource for researchers and clinicians around the world. Find out more at www.amjtransplant.com.
Wiley is a global provider of knowledge and knowledge-enabled services that improve outcomes in areas of research, professional practice and education. Through the Research segment, the Company provides digital and print scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising. The Professional Development segment provides digital and print books, online assessment and training services, and test prep and certification. In Education, Wiley provides education solutions including online program management services for higher education institutions and course management tools for instructors and students, as well as print and digital content. The Company’s website can be accessed at www.wiley.com. .
Dawn Peters (US) +1 781-388-8408
Tom Griffin (UK) +44 (0) 1865 476213